Michael Schmidt
Stock Analyst at Guggenheim
(4.95)
# 67
Out of 5,182 analysts
129
Total ratings
72.12%
Success rate
58.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $160 → $175 | $131.67 | +32.91% | 6 | Apr 14, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Buy | $6 → $10 | $4.25 | +135.29% | 5 | Apr 10, 2026 | |
| NBTX Nanobiotix | Maintains: Buy | $26 → $36 | $32.83 | +9.66% | 4 | Apr 2, 2026 | |
| CMPX Compass Therapeutics | Reiterates: Buy | $12 | $1.79 | +570.39% | 6 | Mar 24, 2026 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $10 → $15 | $4.29 | +249.65% | 3 | Mar 18, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintains: Buy | $34 → $30 | $19.29 | +55.52% | 3 | Mar 18, 2026 | |
| ERAS Erasca | Maintains: Buy | $12 → $20 | $19.15 | +4.44% | 2 | Mar 16, 2026 | |
| XFOR X4 Pharmaceuticals | Initiates: Buy | $12 | $4.21 | +185.04% | 1 | Mar 9, 2026 | |
| TNGX Tango Therapeutics | Maintains: Buy | $18 → $20 | $26.33 | -24.04% | 3 | Mar 6, 2026 | |
| ONC BeOne Medicines AG | Maintains: Buy | $400 → $410 | $298.90 | +37.17% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $26.64 | +50.15% | 4 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $23.49 | +49.00% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $5.21 | +130.33% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $125 | $95.72 | +30.60% | 7 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.76 | +165.96% | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $10.19 | +76.64% | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $10.29 | +45.77% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $36.61 | -53.56% | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $30.33 | +48.37% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $23.77 | -36.90% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $86.68 | -40.01% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $14.95 | -33.11% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $21.00 | +52.38% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.54 | +152.71% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $23.65 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $44.65 | -5.94% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $2.25 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $4.99 | +300.80% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $28.56 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $112 | $7.93 | +1,312.36% | 4 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.96 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.76 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.25 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $13.10 | +159.54% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $2.30 | +1,029.45% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.01 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $24.43 | +227.47% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.97 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $4.28 | +28.50% | 2 | Nov 7, 2017 |
Revolution Medicines
Apr 14, 2026
Maintains: Buy
Price Target: $160 → $175
Current: $131.67
Upside: +32.91%
Zentalis Pharmaceuticals
Apr 10, 2026
Maintains: Buy
Price Target: $6 → $10
Current: $4.25
Upside: +135.29%
Nanobiotix
Apr 2, 2026
Maintains: Buy
Price Target: $26 → $36
Current: $32.83
Upside: +9.66%
Compass Therapeutics
Mar 24, 2026
Reiterates: Buy
Price Target: $12
Current: $1.79
Upside: +570.39%
CytomX Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $10 → $15
Current: $4.29
Upside: +249.65%
Monte Rosa Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $19.29
Upside: +55.52%
Erasca
Mar 16, 2026
Maintains: Buy
Price Target: $12 → $20
Current: $19.15
Upside: +4.44%
X4 Pharmaceuticals
Mar 9, 2026
Initiates: Buy
Price Target: $12
Current: $4.21
Upside: +185.04%
Tango Therapeutics
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $20
Current: $26.33
Upside: -24.04%
BeOne Medicines AG
Feb 27, 2026
Maintains: Buy
Price Target: $400 → $410
Current: $298.90
Upside: +37.17%
Feb 23, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $26.64
Upside: +50.15%
Dec 16, 2025
Maintains: Buy
Price Target: $25 → $35
Current: $23.49
Upside: +49.00%
Nov 7, 2025
Initiates: Buy
Price Target: $12
Current: $5.21
Upside: +130.33%
Nov 3, 2025
Upgrades: Buy
Price Target: $125
Current: $95.72
Upside: +30.60%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $3.76
Upside: +165.96%
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $10.19
Upside: +76.64%
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $10.29
Upside: +45.77%
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $36.61
Upside: -53.56%
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $30.33
Upside: +48.37%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $23.77
Upside: -36.90%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $86.68
Upside: -40.01%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $14.95
Upside: -33.11%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $21.00
Upside: +52.38%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $5.54
Upside: +152.71%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $23.65
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $44.65
Upside: -5.94%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $2.25
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $4.99
Upside: +300.80%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $28.56
Upside: -
Sep 30, 2024
Upgrades: Buy
Price Target: $112
Current: $7.93
Upside: +1,312.36%
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.96
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.76
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.25
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $13.10
Upside: +159.54%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $2.30
Upside: +1,029.45%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.01
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $24.43
Upside: +227.47%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $7.97
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $4.28
Upside: +28.50%